Recently Featured

Moderna pays up to $2.25bn to settle drug delivery tech patent lawsuit

March 22, 2026
Moderna has agreed to a settlement of up to $2.25 billion to resolve a patent infringement lawsuit related to its drug delivery technology, brought forth by Genevant and Arbutus. This settlement comes just days before a jury trial was scheduled to commence, highlighting the urgency and significance of the legal dispute. The lawsuit centered around…

Healthcare Transformation Accelerates with AI Innovations from San Francisco

March 22, 2026
Recent developments in healthcare technology, particularly in artificial intelligence, indicate a significant transformation within the industry. During a recent event hosted by Lux Capital in San Francisco, key industry leaders showcased groundbreaking AI applications aimed at enhancing patient care and streamlining operations. This shift towards AI-driven solutions is not merely a trend; it represents a…

China is taking on the world’s 10 most expensive medicines

March 22, 2026
In a significant move, Chinese regulators have approved Belief BioMed’s gene therapy for hemophilia B, positioning it as a direct competitor to some of the world’s most expensive medicines. This approval not only marks the introduction of the first hemophilia gene therapy in China but also signals a broader trend where Chinese pharmaceutical companies aim…

Pediatric Nicotine Exposure Shifts with Trends

March 22, 2026
Recent studies indicate a notable increase in pediatric nicotine exposure, primarily driven by the rising prevalence of vaping among adolescents. This shift in exposure patterns raises significant concerns for public health officials and regulatory bodies, as the long-term effects of nicotine on developing brains remain inadequately understood. The growing use of e-cigarettes has made nicotine…

Ongoing Cases